Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The Authors’ Reply

The Authors’ Reply Am J Cardiovasc Drugs 2011; 11 (4): 285 CORRESPONDENCE 1175-3277/11/0004-0285/$49.95/0 ª 2011 Adis Data Information BV. All rights reserved. 2. Johnson ES, Weinstein JR, Thorp ML, et al. Predicting the risk of hyperkalemia The Correct in patients with chronic kidney disease starting lisinopril. Pharmacoepidemiol Drug Saf 2010 Mar; 19 (3): 266-72 Administration of Antihypertensive Drugs According to the The problem raised in the letter is correct and needs to be carefully taken into account when using ACE inhibitors in Principles of Clinical patients with kidney disease. On the other hand, the principle [1] aim of our paper was to discuss the utilization of ACE Pharmacology inhibitors in patients with essential hypertension. In this case the major problem we observe in clinical practice is the utiliza- [1] Taddei et al. have done a great job in explaining the flat tion of these drugs at a dose not sufficient to ensure adequate dose-response relationship of ACE inhibitors on BP reduction. 24-hour BP control or not effective in reducing cardiovascular Based on this, once we know that a patient tolerates (i.e. risk. Usually in patients with normal renal function the risk of without hypotension) a lower dose then we can safely go http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png American Journal of Cardiovascular Drugs Springer Journals

The Authors’ Reply

Download PDF
1 page

The Authors’ Reply

Abstract

Am J Cardiovasc Drugs 2011; 11 (4): 285 CORRESPONDENCE 1175-3277/11/0004-0285/$49.95/0 ª 2011 Adis Data Information BV. All rights reserved. 2. Johnson ES, Weinstein JR, Thorp ML, et al. Predicting the risk of hyperkalemia The Correct in patients with chronic kidney disease starting lisinopril. Pharmacoepidemiol Drug Saf 2010 Mar; 19 (3): 266-72 Administration of Antihypertensive Drugs According to the The problem raised in the letter is correct and needs to be carefully taken into...
Loading next page...
 
/lp/springer-journals/the-authors-reply-DeYuirLlPB

References (1)

Publisher
Springer Journals
Copyright
Copyright © 2011 by Adis Data Information BV
Subject
Medicine & Public Health; Cardiology; Pharmacotherapy; Pharmacology/Toxicology
ISSN
1175-3277
eISSN
1179-187X
DOI
10.2165/11533620-000000000-00000
pmid
21740080
Publisher site
See Article on Publisher Site

Abstract

Am J Cardiovasc Drugs 2011; 11 (4): 285 CORRESPONDENCE 1175-3277/11/0004-0285/$49.95/0 ª 2011 Adis Data Information BV. All rights reserved. 2. Johnson ES, Weinstein JR, Thorp ML, et al. Predicting the risk of hyperkalemia The Correct in patients with chronic kidney disease starting lisinopril. Pharmacoepidemiol Drug Saf 2010 Mar; 19 (3): 266-72 Administration of Antihypertensive Drugs According to the The problem raised in the letter is correct and needs to be carefully taken into account when using ACE inhibitors in Principles of Clinical patients with kidney disease. On the other hand, the principle [1] aim of our paper was to discuss the utilization of ACE Pharmacology inhibitors in patients with essential hypertension. In this case the major problem we observe in clinical practice is the utiliza- [1] Taddei et al. have done a great job in explaining the flat tion of these drugs at a dose not sufficient to ensure adequate dose-response relationship of ACE inhibitors on BP reduction. 24-hour BP control or not effective in reducing cardiovascular Based on this, once we know that a patient tolerates (i.e. risk. Usually in patients with normal renal function the risk of without hypotension) a lower dose then we can safely go

Journal

American Journal of Cardiovascular Drugs – Springer Journals

Published: Aug 17, 2012

There are no references for this article.